Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

NCT00002070 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Sargramostim
DRUG: Ganciclovir

Sponsor

Schering-Plough